Pretzel Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
854 Lexington St Ste 154, Waltham, Massa...Website
www.pretzeltx.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
1
1
1
About Pretzel Therapeutics
Pretzel Therapeutics is focused on developing transformative medicines targeting mitochondrial dysfunction, aiming to revolutionize mitochondrial therapeutics. The company has a robust pipeline of first-in-class treatments that address unmet medical needs in conditions including neurological disorders, muscular atrophies, and rare diseases. By leveraging cellular energetics, Pretzel is committed to creating innovative therapeutic options to slow disease progression and improve patient outcomes. Their intended clients include individuals suffering from both rare and common conditions linked to mitochondrial issues.Explore more
Pretzel Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pretzel Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Pretzel Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Pretzel Therapeutics
Click to see if Pretzel Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Pretzel Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Pretzel Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Pretzel Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Pretzel Therapeutics has new funding data
Check if Pretzel Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Pretzel Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Pretzel Therapeutics
Compare insights from companies similar to Pretzel Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pretzel Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pretzel Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pretzel Therapeutics.
Pretzel Therapeutics Tech Stack
A closer look at the technologies used by Pretzel Therapeutics
Most Recent Scoops
Open Position
Open Position
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Pretzel Therapeutics News & Media
Pretzel Therapeutics Announces Publication in Nature Unveiling Discovery of Novel Small Molecule Activators for the Treatment of POLG Disorders and Other Conditions Related to mtDNA Depletion
WALTHAM, Mass.--(BUSINESS WIRE)-- #pipeline--Pretzel Therapeutics, a leader in harnessing cellular energetics to develop novel treatments for a range of conditions spanning neurological, muscular atrophies, metabolic and rare disease, today announced the publication of new research findings in Nature elucidating a novel disease-modulating mechanism of action for the treatment of mitochondrial DNA (mtDNA) depletion syndromes. The article, “Small Molecules Restore Mutant Mitochondrial DNA PolymeraPretzel Therapeutics Initiates Phase 1 Clinical Study Evaluating PX578, Lead Therapeutic in its Bioenergetics Restoration Franchise
WALTHAM, Mass.--(BUSINESS WIRE)-- #pipeline--Pretzel Therapeutics has initiated recruitment in a Phase 1 clinical study of PX578, the lead therapeutic in its bioenergetics restoration franchise.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pretzel Therapeutics
Sign Up For FreeTo access detailed company insights
Pretzel Therapeutics is focused on developing transformative medicines targeting mitochondrial dysfunction, aiming to revolutionize mitochondrial therapeutics. The company has a robust pipeline of first-in-class treatments that address unmet medical needs in conditions including neurological disorders, muscular atrophies, and rare diseases. By leve... Read More
